Search

everythinglearnresearchcommunity

for

Search:↓

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

Women with a certain type of tumor had higher levels of pregnancy hormone and male hormones, which decreased after treatment.

Finasteride treatment lowers urine androgen and prostaglandin levels, making them potential markers for effectiveness.

Finasteride affects brain and blood steroids, causing lasting sexual and emotional side effects.

PRP treatment can safely boost hormone levels in some IVF patients with low ovarian reserve.

Using micro-needling, low-level laser therapy, and platelet-rich plasma together significantly improves hair growth in people with hair loss.

Simvastatin may help manage symptoms in women with non-classic congenital adrenal hyperplasia by lowering cholesterol and certain hormone levels.

Certain gene variations are linked to higher male hormone levels in Chinese women with PCOS and insulin resistance.

A new gene, JMJD1C, may affect testosterone levels in men.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Platelet-rich plasma treatment can significantly increase hair count and density in men with pattern baldness, and these improvements can last up to 3 months.

Orlistat helped reduce weight and testosterone in obese women with PCOS but did not significantly affect other androgens or cholesterol levels.

AR gene not major factor in female hair loss; different from male hair loss.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

Lower testosterone levels in men may be linked to a higher risk of severe coronary artery disease.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

Early onset hair loss linked to genetics and androgen levels.

Higher androgen levels do not cause baldness in men.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Ovarian Leydig cell tumors are hard to diagnose with just advanced imaging; expert ultrasound and clinical evaluation are essential.

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.

Many young women who donate blood have hormonal disorders like excess male hormones and PCOS.

Gene variant linked to prostate cancer, hormone levels, and hair loss.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.